FDA approves Agios Pharmaceuticals’ Tibsovo for acute myeloid leukemia
The approval is the latest of several drugs approved for the disease, a form of blood cancer, since last year.
Agios: You may not have to kill cancer to conquer it
Killing cancer cells isn’t the only way to keep the disease at bay, researchers are learning: Coaxing immature, ill-developed cancer cells to return to their normal function is an alternate approach to controlling malignancies. It’s described nicely in a piece by New Yorker staffer and Harvard medicine chair Jerome Groopman: The Transformation – Is it possible to control cancer without […]
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.